Cyclobenzaprine Hydrochloride Tablet, Film Coated
Product Images NDC 85509-1014

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Cyclobenzaprine Hydrochloride (NDC 85509-1014). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Phoenix Rx Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Label (1014 Cyclobenzaprine 10mg)

Label (1014 Cyclobenzaprine 10mg)
This is a medication package insert for Cyclobenzaprine hydrochloride tablets. Each film-coated tablet contains 10 mg of the active ingredient. The usual dosage information can be obtained by scanning the QR code for prescribing information. The tablets should be stored in a tight, light-resistant container with a child-resistant closure at a temperature between 20°C to 25°C (68°F to 77°F). The product is manufactured by Rubicon Research Private Limited and repackaged by PHOENIX RX LLC in Hatboro, PA, USA. The National Drug Code (NDC) is 85509-1014-3. The tablets are dispensed in a container with 30 tablets. This is a prescription-only medication. The lot number is LOTX85, with an expiration date of July 10, 2026.*
FDA Label Image

Image (Cyclobenzaprine HCl Tabs Structure)

Image (Cyclobenzaprine HCl Tabs Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.